Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0023 | 0.0089 | 0.5 | |
Loa Loa (eye worm) | fructose-bisphosphate aldolase 2 | 0.0088 | 0.1088 | 1 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0089 | 0.0338 |
Leishmania major | fructose-1,6-bisphosphate aldolase | 0.0088 | 0.1088 | 0.392 |
Toxoplasma gondii | fructose-bisphosphate aldolase, putative | 0.0088 | 0.1088 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0089 | 0.0338 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0088 | 0.1088 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0089 | 0.0338 |
Loa Loa (eye worm) | fructose-bisphosphate aldolase 1 | 0.0088 | 0.1088 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0089 | 0.0338 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0089 | 0.0338 |
Brugia malayi | fructose-bisphosphate aldolase 1 | 0.0088 | 0.1088 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0089 | 0.082 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0089 | 0.0338 |
Brugia malayi | fructose-bisphosphate aldolase 2 | 0.0088 | 0.1088 | 1 |
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.0088 | 0.1088 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0672 | 1 | 1 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PTPB (protein-tyrosine-phosphatase) (PTPase) | 0.019 | 0.2636 | 1 |
Leishmania major | phosphoinositide phosphatase | 0.019 | 0.2636 | 1 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0088 | 0.1088 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0017 | 0 | 0.5 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0089 | 0.0338 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0088 | 0.1088 | 1 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0088 | 0.1088 | 1 |
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.0088 | 0.1088 | 0.5 |
Entamoeba histolytica | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase, putative | 0.0055 | 0.0571 | 1 |
Plasmodium vivax | fructose 1,6-bisphosphate aldolase, putative | 0.0088 | 0.1088 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0089 | 0.5 |
Trypanosoma brucei | fructose-bisphosphate aldolase, glycosomal, putative | 0.0088 | 0.1088 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0089 | 0.082 |
Trichomonas vaginalis | conserved hypothetical protein | 0.019 | 0.2636 | 0.5 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0089 | 0.0338 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpB | 0.019 | 0.2636 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0089 | 0.082 |
Leishmania major | hypothetical protein, unknown function | 0.0055 | 0.0571 | 0.189 |
Plasmodium falciparum | fructose-bisphosphate aldolase | 0.0088 | 0.1088 | 1 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0055 | 0.0571 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0089 | 0.0338 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0089 | 0.0338 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0023 | 0.0089 | 0.5 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0672 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 10 % | Inhibition of [3H]E2 binding to human placental 17beta-HSD2 at 1 uM after 20 mins | ChEMBL. | 21211981 |
Inhibition (binding) | = 25 % | Inhibition of [3H]E1 binding to human placental 17beta-HSD1 at 1 uM after 20 mins | ChEMBL. | 21211981 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.